vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Streamex Corp. (STEX). Click either name above to swap in a different company.
Streamex Corp. runs the higher net margin — 155840.0% vs -54.6%, a 155894.6% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
CBLL vs STEX — Head-to-Head
Income Statement — Q4 2025 vs Q3 2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $-10.0K |
| Net Profit | $-13.5M | $-15.6M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | 61130.0% |
| Net Margin | -54.6% | 155840.0% |
| Revenue YoY | — | — |
| Net Profit YoY | — | -714.2% |
| EPS (diluted) | $-0.35 | $-0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | — | ||
| Q3 25 | $22.6M | $-10.0K | ||
| Q2 25 | $21.2M | $13.0K | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | — | $13.0K | ||
| Q3 24 | $17.2M | $0 | ||
| Q2 24 | — | $13.0K | ||
| Q1 24 | — | $14.0K |
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $-15.6M | ||
| Q2 25 | $-13.6M | $-20.4M | ||
| Q1 25 | $-12.8M | — | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | $-10.4M | $-1.9M | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | — | $-3.4M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | — | ||
| Q3 25 | -64.8% | 61130.0% | ||
| Q2 25 | -70.5% | -156653.8% | ||
| Q1 25 | -69.3% | — | ||
| Q4 24 | — | -9100.0% | ||
| Q3 24 | -57.8% | — | ||
| Q2 24 | — | -40707.7% | ||
| Q1 24 | — | -24550.0% |
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | 155840.0% | ||
| Q2 25 | -64.4% | -156707.7% | ||
| Q1 25 | -62.4% | — | ||
| Q4 24 | — | -8453.8% | ||
| Q3 24 | -60.6% | — | ||
| Q2 24 | — | -30115.4% | ||
| Q1 24 | — | -24300.0% |
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.37 | $-0.47 | ||
| Q2 25 | $-0.38 | $-0.74 | ||
| Q1 25 | $-0.36 | — | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | $-1.85 | $-0.12 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $155.3M | $-7.0M |
| Total Assets | $195.8M | $130.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $155.3M | — | ||
| Q3 25 | $164.1M | $-7.0M | ||
| Q2 25 | $172.2M | $-3.6M | ||
| Q1 25 | $180.9M | — | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-136.0M | $-405.0K | ||
| Q2 24 | — | $-6.0K | ||
| Q1 24 | — | $-4.3M |
| Q4 25 | $195.8M | — | ||
| Q3 25 | $199.5M | $130.5M | ||
| Q2 25 | $207.7M | $109.7M | ||
| Q1 25 | $213.5M | — | ||
| Q4 24 | — | $842.0K | ||
| Q3 24 | $47.1M | $1.4M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | — | $1.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $-5.0M |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | — | ||
| Q3 25 | $-11.1M | $-5.0M | ||
| Q2 25 | $-7.5M | $-1.3M | ||
| Q1 25 | $-11.4M | — | ||
| Q4 24 | — | $-474.0K | ||
| Q3 24 | — | $-1.5M | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-1.3M |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
STEX
Segment breakdown not available.
